Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity
Clinical trial NCT02873819 · COMPLETED
Trial details
- NCT number
- NCT02873819
- Sponsor
- Gliknik Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-30
- Primary completion
- 2021-05-17
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.